Back to JNJ Stock Lookup

JNJ Related Analyst Ratings

Apr 19, 2013 08:18 AM Jefferies Trims Estimates, Ups PT on Johnson & Johnson (JNJ) Post Q1

Apr 17, 2013 10:49 AM Goldman Maintains Sell on Johnson & Johnson (JNJ); Drug Business Spin Still Unlikely

Apr 10, 2013 08:30 AM Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)

Apr 8, 2013 07:19 AM JPMorgan Downgrades Johnson & Johnson (JNJ) to Neutral

Apr 1, 2013 11:47 AM Amarin's (AMRN) Vascepa Tracking Well 3-Months In; Investors Eye Tier 2 Designation

Mar 26, 2013 04:24 PM Q1 Not Super Important for Johnson & Johnson (JNJ), But New Products Are - UBS

Feb 28, 2013 03:47 PM Medivation (MDVN) Reverses after Cowen Research Called into Question by Janney

Feb 7, 2013 06:55 AM Credit Suisse Downgrades Johnson & Johnson (JNJ) to Underperform

Jan 4, 2013 07:27 AM Deutsche Bank Upgrades Johnson & Johnson (JNJ) to Buy; Well-Diversified and Positioned

Dec 10, 2012 12:18 PM Davenport Upgrades Johnson & Johnson (JNJ) to Buy

Nov 20, 2012 08:48 AM Stifel Nicolaus Starts Johnson & Johnson (JNJ) at Hold

Nov 12, 2012 07:00 AM Jefferies Downgrades Johnson & Johnson (JNJ) to Hold, Easy Money Made

Oct 9, 2012 07:25 AM Goldman Sachs Downgrades Johnson & Johnson (JNJ) to Sell, Sees Limited Upside

Sep 26, 2012 11:29 AM Refinancing of Debt Helps Alkermes (ALKS) Save Cash, MKM Reiterates Buy, Raises PT

Sep 19, 2012 10:22 AM Wedbush Prostate Cancer Survey Reveals JNJ’s (JNJ) Zytiga has Still-Solid Market Position but Medivation’s (MDVN) Xtandi in Good Position at Launch

Sep 11, 2012 08:16 AM Credit Suisse Reinstates Johnson & Johnson (JNJ) at Neutral

Sep 4, 2012 01:55 PM Wedbush Reiterates an 'Outperform' on Medivation (MDVN); Raising PT on Early Approval

Sep 4, 2012 10:51 AM Leerink Swann Maintains an 'Outperform' on Medivation (MDVN); Number of Advantages Based on Labeling

Aug 6, 2012 09:19 AM Sell-Off in VIVUS (VVUS) Over Qsymia Patent Concerns is Overdone - Analyst

Aug 1, 2012 12:10 PM UBS Reiterates a 'Buy' on Johnson & Johnson (JNJ); Diving Into Valuation

Jul 30, 2012 03:15 PM Maxim Upgrades Dendreon (DNDN) as the Street is 'Too Bearish' Ahead of Q2 Results

Jul 25, 2012 12:52 PM Canaccord Genuity Afternoon Coffee on PFE, ELN, and JNJ: I Just Forgot What I Was About to Say

Jul 24, 2012 02:16 PM UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); Bapineuzumab Misses on ApoE4 Carriers

Jul 24, 2012 10:15 AM Canaccord Genuity Morning Coffee on Dogs of the Dow: I'm Large and In Charge

Jul 18, 2012 11:31 AM Jefferies Boosts PT on J&J (JNJ) Following Q2 Results; Watching 'Strategic Review,' Synthes Integration

Jul 17, 2012 09:10 AM RBC Capital Negative on Dendreon (DNDN) Ahead of Q2 Results

Jul 16, 2012 02:24 PM Q2 Preview: Eyes on J&J's (JNJ) New CEO Gorsky Into Print, Conference Call

Jul 16, 2012 09:49 AM S&P 500 (SPY) is Going Higher Because Analyst Carter Worth Says So

Jul 13, 2012 08:32 AM Jefferies on Pharmaceuticals: Global Pharmaceuticals Q2'12 Earnings Preview; Where is it Safe to Hide?

Jul 12, 2012 09:10 AM Citi Removes Apple (AAPL) from 'Champions' List; Adds GE (GE), J&J (JNJ), Ford (F)

Jun 29, 2012 03:51 PM Barclays on Pharmaceutical Stocks: Impact as SCOTUS Upholds Entire Affordable Care Act

Jun 21, 2012 12:28 PM Analyst Sees Dendreon's (DNDN) Efforts to Boost Provenge Demand Bearing Fruit in Q4; Shares Jump

Jun 14, 2012 11:27 AM Canccord Genuity Morning Coffee on Johnson & Johnson (JNJ); Good for the Bones, ja!

Jun 13, 2012 07:52 AM Jefferies Upgrades Johnson & Johnson (JNJ) to Buy, Boosts Target to $72

Jun 13, 2012 07:47 AM Raymond James Upgrades J&J (JNJ) to Outperform

Jun 13, 2012 07:18 AM JPMorgan Upgrades Johnson & Johnson (JNJ) to Overweight

Jun 12, 2012 11:37 AM UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); CANA Standout at ADA

Jun 12, 2012 10:19 AM Canaccord Genuity Morning Coffee on Johnson & Johnson (JNJ): Big Legal Bills To Get Bigger

Jun 11, 2012 05:17 PM Barclays on Global Biopharma Stocks: American Diabetes Association 2012: Highlights From GSK, LLY, SNY, NVO & JNJ

Jun 4, 2012 11:33 AM Deutsche Bank Defends Dendreon (DNDN) Despite Strong Zytiga Data; Maintains Buy

Jun 4, 2012 09:37 AM Brean Murray Carret & Co. Maintains a 'Buy' on Medivation (MDVN); Zytiga Data Better Than Expected

Jun 4, 2012 09:29 AM Deutsche Bank Maintains a 'Hold' on Johnson & Johnson (JNJ); Phase 3 Data for Zytiga Shows Meaningful Results

Jun 4, 2012 09:09 AM Wedbush Reiterates an 'Outperform' on Medivation (MDVN); Raising PT and 2013 Estimates

May 17, 2012 10:40 AM Dendreon (DNDN) Hit On Various Worries, Deutsche Bank Defends

May 16, 2012 10:20 AM Canaccord Genuity Morning Coffee on Avon Products (NYSE: AVP): Even Concealer Can't Fix This Mess

May 11, 2012 01:26 PM Barclays on Healthcare: Top Takeaways from our Second Annual Therapeutics Symposium

May 9, 2012 10:40 AM Auriga Maintains a 'Buy' on Perrigo Co. (PRGO); Accumulate Shares on Weakness

May 1, 2012 02:39 PM Cantor Fitzgerald Maintains a 'Buy' on Warner Chilcott (WCRX); Let's Make It Official

Apr 23, 2012 10:14 AM Auriga Reiterates a 'Buy' on Perrigo Co. (PRGO); Recent Data Points Underscore Thesis

Apr 18, 2012 01:14 PM UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); Held Back By Slow EPS Growth

Back to JNJ Stock Lookup